journal article·2020

Tandem post-synthetic modification of a zeolitic imidazolate framework for CXCR4-overexpressed esophageal squamous cell cancer imaging and therapy

Yi Cao, Zhenqi Jiang, Yanying Li, Yinjie Wang, Yong Yang, Ozioma Udochukwu Akakuru, Juan Li, Aiguo Wu

Nanoscale· Volume 12· Issue 24
Publisher page

Abstract

-weighted magnetic resonance imaging performance and CXCR4 targeting ability. With 5-Fu loading, AMD-ZIF-7(Mn)/5-Fu showed a synergistic therapeutic effect in DNA damage and CXCR4 inhibition of esophageal squamous cell cancer. Therefore, we propose a structural reconstruction method to effectively explore and improve the biomedical application of ZIFs in esophageal squamous cell cancer theranostics.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Esophageal Cancer Research and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Cixi Institute of Biomedical Engineering

CAS Key Laboratory of Magnetic Materials and Devices

Zhejiang Engineering Research Center for Biomedical Materials

Ningbo Institute of Materials Technology and Engineering

Chinese Academy of Sciences

Department of Clinical Laboratory

the Affiliated Hospital of Medical School of Ningbo University

Ningbo University School of Medicine

Ningbo

P.R. China

Funding

National Basic Research Program of China · National Natural Science Foundation of China · Youth Innovation Promotion Association of the Chinese Academy of Sciences

References (43)

Show source-provided references
1. Jemal · Cancer Epidemiol. Biomarkers Prev. · 2010 · 19 · 189310.1158/1055-9965.EPI-10-0437 ↗
2. Bray · CA–Cancer J. Clin. · 2018 · 68 · 39410.3322/caac.21492 ↗
3. Song · Nature · 2014 · 509 · 9110.1038/nature13176 ↗
4. Umar · Nat. Clin. Pract. Gastroenterol. Hepatol. · 2008 · 5 · 51710.1038/ncpgasthep1223 ↗
5. Chen · CA–Cancer J. Clin. · 2016 · 66 · 11510.3322/caac.21338 ↗
6. van Hagen · N. Engl. J. Med. · 2012 · 366 · 207410.1056/NEJMoa1112088 ↗
8. Enzinger · N. Engl. J. Med. · 2003 · 349 · 224110.1056/NEJMra035010 ↗
9. Nishimaki · Ann. Surg. · 1994 · 220 · 77510.1097/00000658-199412000-00011 ↗
10. Bosset · N. Engl. J. Med. · 1997 · 337 · 16110.1056/NEJM199707173370304 ↗
11. Wang · Oncotarget · 2017 · 8 · 3614910.18632/oncotarget.15254 ↗
12. Fang · Clin. Cancer Res. · 2018 · 24 · 104810.1158/1078-0432.CCR-17-1756 ↗
13. Lu · J. Thorac. Cardiovasc. Surg. · 2015 · 150 · 38610.1016/j.jtcvs.2015.05.030 ↗
14. Zhao · Oncotarget · 2015 · 6 · 502210.18632/oncotarget.3217 ↗
15. Sasaki · J. Surg. Oncol. · 2008 · 97 · 43310.1002/jso.20976 ↗
16. Lennerz · J. Clin. Oncol. · 2011 · 29 · 480310.1200/JCO.2011.35.4928 ↗
17. Hanawa · Int. J. Cancer · 2006 · 118 · 117310.1002/ijc.21454 ↗
19. Kitadai · Int. J. Cancer · 2001 · 93 · 66210.1002/ijc.1379 ↗
20. Wang · Adv. Mater. · 2017 · 29 · 160379410.1002/adma.201603794 ↗
21. Huang · J. Am. Chem. Soc. · 2010 · 132 · 1556210.1021/ja108774v ↗
22. Qin · ACS Appl. Mater. Interfaces · 2019 · 11 · 1174310.1021/acsami.8b21425 ↗
23. Jiang · Biomaterials · 2019 · 197 · 4110.1016/j.biomaterials.2019.01.001 ↗
24. Horcajada · Chem. Rev. · 2012 · 112 · 123210.1021/cr200256v ↗
25. Li · Adv. Funct. Mater. · 2016 · 26 · 271510.1002/adfm.201504998 ↗
26. Su · ACS Appl. Mater. Interfaces · 2019 · 11 · 1052010.1021/acsami.8b22177 ↗
27. Lismont · Adv. Funct. Mater. · 2017 · 27 · 160631410.1002/adfm.201606314 ↗
28. Wu · Biomaterials · 2018 · 162 · 13210.1016/j.biomaterials.2018.02.022 ↗
29. Fei · Inorg. Chem. · 2013 · 52 · 401110.1021/ic400048g ↗
30. Gai · Chem. Commun. · 2018 · 54 · 1210910.1039/C8CC07064D ↗
31. Chen · Chem. Commun. · 2014 · 50 · 865110.1039/C4CC02818J ↗
32. Chocarro-Ruiz · J. Mater. Chem. A · 2018 · 6 · 1317110.1039/C8TA02767F ↗
33. Jiang · Nano-Micro Lett. · 2019 · 11 · 6110.1007/s40820-019-0292-y ↗
34. Zhao · ACS Omega · 2018 · 3 · 979010.1021/acsomega.8b00923 ↗
35. Park · Proc. Natl. Acad. Sci. U. S. A. · 2006 · 103 · 1018610.1073/pnas.0602439103 ↗
36. Wong · Mol. Pharmacol. · 2008 · 74 · 148510.1124/mol.108.049775 ↗
37. Chow · PLoS One · 2016 · 11 · 19
38. Uchida · Oncol. Rep. · 2018 · 40 · 303
39. Kadota · Inorg. Chem. · 2017 · 56 · 874410.1021/acs.inorgchem.7b01322 ↗
40. Liu · Biomaterials · 2016 · 97 · 110.1016/j.biomaterials.2016.04.034 ↗
41. Shen · Adv. Mater. · 2018 · e180316310.1002/adma.201803163 ↗
42. Atkovska · Int. J. Mol. Sci. · 2014 · 15 · 262210.3390/ijms15022622 ↗
43. Papathanasopoulos · AIDS Res. Hum. Retroviruses · 2002 · 18 · 87910.1089/08892220260190362 ↗